LevelStock.com: Stock to Watch! Power 3 Medical Products, Inc. Has Targeted Several Key Acquisition Candidates
May 10th 2010, (CRWE NEWS WIRE) Braintree,Ma. LevelStock.com is pleased to announce to all of its members and investors information on Power3 Medical Products, Inc. (OTCBB: PWRM). The Company recently released news as follows:
LevelStock.com is pleased to announce its Daily Stock to Watch
We encourage investors to join the FREE daily e-mail alerts by visiting:
http://www.levelstock.com
Power3 Medical Products, Inc. (OTCBB: PWRM) reported that the company has targeted several key acquisition candidates that own or have exclusive rights to market certain complementary assets and technologies that will enhance its intellectual property portfolio. Power3 intends to evaluate opportunities that can provide it with, among other things, promising stem cell research, patents and other intellectual property assets, new technologies, and key personnel or capabilities, that could augment these efforts.
“We intend to take advantage of acquisition opportunities to augment our in-house product development programs,” stated Dr. Ira L. Goldknopf, President and Chief Scientific Officer of Power3. “We recognize that we cannot meet all of our research and discovery needs internally and can benefit from the research performed by other organizations. We will continue to identify additional companies and technologies that we believe will contribute significantly to enhancing Power3 shareholder value.”
In accordance with provisions of the merger agreement, the company has elected to terminate the merger agreement with StemTroniX, Inc., a Texas corporation, previously announced by Power3 on February 11, 2010, and temporarily restrained from completing due to issues solely related to StemTroniX. Notwithstanding this, the company has been assured full assignment of the recently filed provisional patent application entitled, “Stem cell protein biomarkers and their use in monitoring stem cells and their products for stem cell therapy.” Power3 also announced its intention to acquire additional stem cell companies, technologies and intellectual property.
About Power3 Medical Products
Power3 is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which its has completed Phase I clinical trials, and NuroPro, a serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, currently engaged in Phase II clinical trials. These products are designed to analyze proteins and their mutations to assess an individual’s risk for developing disease later in life, a patient’s likelihood of responding to a particular drug, a patient’s risk of disease progression and disease recurrence, to measure a patient’s exposure to drug therapy, to ensure optimal dosing and reduced drug toxicity.
About LevelStock.com
We are an investor community and investors relations website specializing in emerging growth stocks in today’s Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies.
We encourage everyone to join our social media sites:
Free Subscription For Our Newsletters: http://www.levelstock.com/
FaceBook: http://www.facebook.com/group.php?gid=283660480870
Twitter: http://twitter.com/levelstock
LevelStock.com is not a registered investment advisor or broker-dealer. The information here is believed to be reliable, but not guaranteed to be accurate by LevelStock.com Please be advised that the information contained may or may not be complete and is solely for informational purposes only. Please read our full disclaimer for complete risks and disclosures http://levelstock.bondwaresite.com/news.php?viewStory=19
CONTACT INFO: LevelStock.com 288 Grove Street Suite 181, Braintree, MA 02184
Email: support@levelstock.com
|